Why We Need a Universal Influenza Vaccine Every year, millions of people roll up their sleeves for a flu shot, and every year, that same shot needs reformulating. This isn’t bureaucratic inefficiency — it’s...
Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...
Summary This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing progress across three themes (pipeline diversification, preclinical/clinical acceleration...
1. Five years after the global TB vaccine roadmap launched, progress is real but painfully thin This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing...
Ebola virus disease (Bundibugyo, DRC) The Ebola outbreak due to the Bundibugyo virus in the Democratic Republic of the Congo continues to expand and is currently the most significant acute hemorrhagic fever emergency...
Long COVID: an update for your medical practice Long COVID is best conceptualized as one or several post‑infectious syndromes: a disease with a known trigger (SARS‑CoV‑2 infection) that develops in only a definable...
Pregnancy is still a paradigmatic “stress test” for host defense against infection, but the picture has broadened considerably since the 2014 Kourtis review. The core message remains that pregnancy does not globally...
The UK Health Security Agency leaflet is a concise, well‑written guide to meningococcal group B (MenB) vaccination for teenagers and young adults in the UK. It explains in plain language why MenB matters, who is...
1. Avian influenza reaches European dairy herds – silent spread in cattle demands integrated surveillance A farm-based investigation in the Netherlands screened milk and serum from 72 lactating cows and 38 youngstock...
The 2026 Bundibugyo ebolavirus outbreak in eastern DR Congo and Uganda has triggered an unprecedented acceleration of vaccine development for a strain that, until now, had no candidates even in Phase 1 trials. As of 22...